Trends in health care resource use for hepatitis C virus infection in the United States†
Article first published online: 29 NOV 2005
Copyright © 2005 American Association for the Study of Liver Diseases
Volume 42, Issue 6, pages 1406–1413, December 2005
How to Cite
Grant, W. C., Jhaveri, R. R., McHutchison, J. G., Schulman, K. A. and Kauf, T. L. (2005), Trends in health care resource use for hepatitis C virus infection in the United States. Hepatology, 42: 1406–1413. doi: 10.1002/hep.20941
Potential conflict of interest: Nothing to report.
- Issue published online: 29 NOV 2005
- Article first published online: 29 NOV 2005
- Manuscript Accepted: 7 SEP 2005
- Manuscript Received: 7 APR 2005
- Novartis Pharmaceuticals Corporation, East Hanover, NJ
- 2Centers for Disease Control and Prevention. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR Recomm Rep 1998; 47(RR-19): 1–39.
- 8National Center for Health Statistics. Third National Health and Nutrition Examination Survey, 1988–1994, NHANES III. Hyattsville, MD: National Center for Health Statistics, 1996.
- 11HCUPnet, Healthcare Cost and Utilization Project, Nationwide Inpatient Sample, 1994–2001. Rockville, MD: Agency for Healthcare Research and Quality, 2004.
- 12National Center for Health Statistics. National Ambulatory Medical Care Survey, 1994–2002. Hyattsville, MD: National Center for Health Statistics, 2004.
- 13Verispan Source Prescription Audit. Physician Drug & Diagnosis Audit, 1993–2000. Newtown, PA: Verispan, 2004.